Holdings
Palisades Investment Partners, LLC
As of Jun 30, 2026, Palisades Investment Partners, LLC reported 50 positions worth US$345M. Largest: Spx Technologies, Inc., Krystal Biotech, Inc. and Park Aerospace Corp. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Spx Technologies, Inc. | 128K | US$31.3M | +4,416 | Jun 30, 2026 |
| Krystal Biotech, Inc. | 47,801 | US$17.8M | +2,396 | Jun 30, 2026 |
| Park Aerospace Corp. | 435K | US$16.6M | +18,115 | Jun 30, 2026 |
| Travere Therapeutics, Inc. | 273K | US$15.5M | +17,840 | Jun 30, 2026 |
| Willis Lease Finance Corporation | 63,039 | US$14.4M | +40,700 | Jun 30, 2026 |
| Enova International, Inc. | 59,689 | US$14.4M | +782 | Jun 30, 2026 |
| Ies Holdings, Inc. | 15,003 | US$11M | +382 | Jun 30, 2026 |
| Paymentus Holdings, Inc. | 431K | US$10.4M | +1,762 | Jun 30, 2026 |
| Ufp Technologies, Inc. | 38,826 | US$10.3M | +1,125 | Jun 30, 2026 |
| Veracyte, Inc. | 175K | US$10.3M | +4,431 | Jun 30, 2026 |